Location History:
- Debrechen, HU (1979)
- Debrecen, HU (1976 - 1993)
Company Filing History:
2 out of 283 
2 out of 5 
1 out of 2 Years Active: 1976-1993
Title: The Innovations of Sandor Makleit
Introduction
Sandor Makleit is a notable inventor hailing from Debrecen, Hungary. With a total of eight patents to his name, he has made significant contributions to the fields of chemistry and pharmaceuticals. His groundbreaking work focuses on novel compounds and innovative processes that aim to advance medical therapies.
Latest Patents
One of Sandor's latest patents is centered around morphinane-skeletoned hydrazone derivatives. This invention relates to new compounds characterized by a specific chemical formula, wherein Y can be either an NH phenyl or NH dinitro phenyl group, Z is a CH2-CH2 segment, R2 is hydroxyl, and R3 may be either hydrogen or methyl. These innovative compounds are designed for use in therapies as analgesic agents or morphine-antagonistic agents. Another significant patent details a novel process for the preparation of substituted chloroacetanilides. This invention allows for the synthesis of chloroacetanilides where R1 and R2 can be independent hydrogen atoms or various alkyl or alkoxy groups.
Career Highlights
Throughout his career, Sandor Makleit has been affiliated with notable companies, including Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. and Chinoin Gyogyszer Es Vegyeszeti. These experiences have provided him with a robust foundation in pharmaceutical development, further enhancing his capabilities as an inventor.
Collaborations
Sandor has collaborated with esteemed colleagues such as Jozsef Knoll and Rezso Bognar. These partnerships have likely contributed to the successful execution of his innovative patents, showcasing the importance of teamwork in advancing scientific discoveries.
Conclusion
In conclusion, Sandor Makleit stands out as a significant figure in the realm of innovation and invention. His eight patents reflect his dedication to improving medical therapies through novel chemical processes and compounds. With continued collaboration and innovation, his contributions may pave the way for future advancements in the pharmaceutical industry.